ZHOU Hui-wen,WANG Jia-jia*,CHI Li,et al.Clinical Research Progress of Treating Ulcerative Colitis with Spleen-invigorating Prescriptions[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2022,46(2):71-76.[doi:10.3969/j.issn.2095-5707.2022.02.016]
健脾类方剂治疗溃疡性结肠炎的临床研究进展
- Title:
- Clinical Research Progress of Treating Ulcerative Colitis with Spleen-invigorating Prescriptions
- 文章编号:
- 2095-5707(2022)02-0071-06
- Keywords:
- ulcerative colitis; spleen-invigorating method; Shenling Baizhu Powder; Lizhong Decoction; Tongxie Yaofang; Sijunzi Decoction; review
- 分类号:
- R269.569
- 文献标志码:
- A
- 摘要:
- 溃疡性结肠炎发病率日益升高,病情复杂多变,易迁延反复,甚至癌变,严重影响患者的身心健康。中医药治疗溃疡性结肠炎具有整体调节的优势,复发率低、不良反应小。众多医家“从脾论治”,应用健脾类方剂治疗溃疡性结肠炎取得显著疗效。本文对近10年应用健脾类方剂如参苓白术散、理中汤、痛泻要方、四君子汤、升阳益胃汤等治疗溃疡性结肠炎的临床研究进行综述,为进一步研究健脾法治疗溃疡性结肠炎的证治规律和病理机制提供参考。
- Abstract:
- In recent years, the incidence of ulcerative colitis is increasing day by day. The disease is complex and changeable, easy to protract and repeat, and even cancerous, which seriously affects the physical and mental health of patients. TCM treatment of ulcerative colitis has the advantages of overall regulation, low recurrence rate and few side effects. Many doctors “treat from the spleen”, and the application of spleen-invigorating prescriptions in the treatment of ulcerative colitis has achieved significant clinical efficacy. This article reviewed the clinical studies on the treatment of ulcerative colitis with spleen-invigorating prescriptions such as Shenling Baizhu Powder, Lizhong Decoction, Tongxie Yaofang, Sijunzi Decoction, Shengyang Yiwei Decoction, etc. in the past 10 years, in order to provide reference for further research on the syndrome treatment and pathological mechanism of spleen-invigorating method in the treatment of ulcerative colitis.
参考文献/References:
[1] 李明松,朱维铭,陈白莉.溃疡性结肠炎——基础研究与临床实践[M].北京:高等教育出版社,2015:1-2.
[2] 刘笃佳,王媛媛,马旭.溃疡性结肠炎的流行病学研究进展[J].中国烧伤创疡杂志,2017,29(3):214-217.
[3] 黄彪,谢璐霜,吴巧凤.溃疡性结肠炎的中西医治疗进展及思考[J].实用医学杂志,2018,34(13):2267-2269,2274.
[4] 郭仕琪,李宇飞,李华山.从“消滞健脾”理论探讨溃疡性结肠炎的诊治[J].中国医药导报,2020,17(4):131-134.
[5] 杨瑾,贾其军,邵荣世.邵荣世从脾虚血瘀辨治溃疡性结肠炎经验介绍[J].新中医,2020,52(12):230-231.
[6] 曹云,郭志玲,何莹,等.田德禄论治溃疡性结肠炎经验[J].北京中医药,2020,39(1):23-26.
[7] 姜慧,李军祥,谭祥,等.李军祥教授治疗溃疡性结肠炎经验[J].中国中西医结合消化杂志,2019,27(3):232-235.
[8] 朱卫,高亚,王爱华,等.王爱华教授辨治溃疡性结肠炎经验[J].湖南中医药大学学报,2017,37(1):48-51.
[9] 裘辉,张智慧,陈素珍,等.周亨德教授辨治溃疡性结肠炎缓解期经验[J].浙江中医药大学学报,2019,43(12):1322-1327.
[10] 罗仕娟,钟子劭,黄穗平,等.从脾失健运探讨慢性溃疡性结肠炎的中医病机和治疗[J].中医药导报,2015,21(13):99-102.
[11] 中华中医药学会脾胃病分会.溃疡性结肠炎中医诊疗专家共识意见(2017)[J].中华中医药杂志,2017,32(8):3585-3589.
[12] 穆丽萍,肖明.参苓白术散治疗溃疡性结肠炎长期应用的疗效与安全性[J].辽宁中医杂志,2016,43(2):309-311.
[13] 张雪.参苓白术散加减配合中药保留灌肠治疗脾胃虚弱型溃疡型结肠炎疗效观察[J].辽宁中医药大学学报,2017,19(3):187-190.
[14] 梁想,王梅青.参苓白术散联合美沙拉嗪治疗溃疡性结肠炎疗效研究[J].陕西中医,2020,41(9):1251-1253.
[15] 周桃梅,杨上文,汪剑波.参苓白术散联合美沙拉嗪治疗溃疡性结肠炎的疗效及对NLRP3炎症小体的影响[J].中国临床药理学与治疗学,2018,23(3):319-324.
[16] 朱凤池,杨静,刘超,等.参苓白术丸联合美沙拉嗪治疗溃疡性结肠炎的疗效观察[J].中国中西医结合外科杂志,2020,26(4):715-718.
[17] 王雪梅.参苓白术散对溃疡性结肠炎患者血浆MMP-2、MMP-9水平的影响[J].环球中医药,2016,9(4):398-401.
[18] 陈天杰,张明红.参苓白术散治疗慢性复发型溃疡性结肠炎的疗效及基于β2AR/β-arrestin2/NF-КB信号转导通路的作用机制[J].中药材,2020,43(4):996-999.
[19] 张晓利,刘建平,刘启泉,等.芩连理中汤治疗慢性复发型溃疡性结肠炎60例临床观察[J].河北中医,2018,40(10):1463-1466,1471.
[20] 卢本银,史仁杰.美沙拉嗪联合附子理中丸治疗脾肾阳虚证溃疡性结肠炎的效果及对血清HIF-1α、SOCS-3水平的影响[J].中国现代医生,2019,57(16):30-33.
[21] 余海平,张建兴,李春耕.附子理中汤加味治疗慢性溃疡性结肠炎的临床评价[J].中国药业,2017,26(13):67-69.
[22] 江山.四君子汤合痛泻要方加减治疗溃疡性结肠炎(脾虚肝郁)临床观察[J].实用中医内科杂志,2020,34(3):83-86.
[23] 王凯,刘利萍,席作武.探讨芍药汤联合痛泻要方对溃疡性结肠炎患者炎症细胞因子及免疫功能的研究[J].中国免疫学杂志,2019,35(5):560-563.
[24] 厉启芳,刘善军,景德怀,等.基于临床疗效及Th1/Th2、Th17/Treg炎性平衡变化探讨痛泻要方治疗溃疡性结肠炎的机制[J].辽宁中医杂志,2018,45(8):1569-1572.
[25] 邓素萍,王小娟.四君子汤加味治疗脾虚夹瘀型溃疡性结肠炎临床观察[J].新中医,2015,47(4):89-90.
[26] 彭洪,林中超,祝秀华.四君子汤加减方治疗溃疡性结肠炎临床疗效观察及对血清IL-33含量的影响[J].中医药学报,2016,44(4):37-41.
[27] 王环,杨晓蓓,白合提尼沙?阿地力.四君子汤合白头翁汤加减治疗慢性溃疡性结肠炎82例效果观察[J].湖南中医药大学学报,2018,38(S1):1186.
[28] 王森.升阳益胃汤治疗脾虚型溃疡性结肠炎的作用机制研究及临床疗效分析[D].南京:南京中医药大学,2018.
[29] 王娅萍.加味升阳益胃汤对溃疡性结肠炎缓解期(脾肾阳虚证)肠屏障功能影响的临床研究[D].晋中:山西中医药大学,2018.
[30] 徐逸,景姗,陈亮,等.健脾化瘀方治疗溃疡性结肠炎临床疗效及对粪钙卫蛋白的影响[J].河北中医,2020,42(7):995-1000,1005.
[31] 张静文.健脾止泻汤联合美沙拉嗪治疗溃疡性结肠炎54例临床研究[J].新中医,2020,52(6):65-67.
[32] 吕九娣.平溃健脾汤联合美沙拉嗪口服治疗溃疡性结肠炎的临床疗效[J].中国肛肠病杂志,2020,40(2):28-29.
[33] 赵胜乾.建中化湿汤联合柳氮磺胺吡啶片治疗溃疡性结肠炎临床观察[J].实用中医药杂志,2020,36(6):755-756.
[34] 郑雪峰,周慧飞.益脾祛湿理肠汤辅助治疗慢性溃疡性结肠炎35例[J].中国中医药科技,2020,27(4):658-659.
[35] 康建媛,张竞超,刘冬厚,等.自拟理肠汤治疗脾虚湿困型溃疡性结肠炎的临床疗效观察[J].中医临床研究,2020,12(10):119-122.
[36] 中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见(2018年,北京)[J].中华消化杂志,2018,38(5):292-311.
相似文献/References:
[1]黄宗日,孙平良*.溃疡性结肠炎穴位疗法研究进展[J].中国中医药图书情报杂志,2021,45(4):74.[doi:10.3969/j.issn.2095-5707.2021.04.018]
HUANG Zong-ri,SUN Ping-liang*.Research Progress of Acupoint Therapy for Ulcerative Colitis[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2021,45(2):74.[doi:10.3969/j.issn.2095-5707.2021.04.018]
备注/Memo
收稿日期:2021-10-20
更新日期/Last Update:
2022-03-15